Fresenius Kabi Taiwan

Part of Fresenius SE & Co. KGaA

CompanyTaiwanFounded 2002

Fresenius Kabi Taiwan develops one asset, in human trials (Renalive LP in chronic kidney disease). Mostly supplement; based in Taiwan, founded in 2002.

1
Asset
Furthest stage: Human trials; 1
Trial: 0
Signals

Pipeline

1

Renalive LP
High-energy, low-protein nutritional formula designed for non-dialysis chronic kidney disease
Human trials, Supplement, chronic kidney disease, low protein dietary intake

Full company profiles: pipeline, trials, funding and people.

In the full profile

Trials1
Similar companies6